Share Price and Basic Stock Data
Last Updated: October 27, 2025, 4:33 pm
| PEG Ratio | -11.85 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Axel Polymers Ltd operates in the plastics industry, focusing on manufacturing plastic and plastic products. The company’s revenue trends have shown significant growth, with sales rising from ₹72.91 Cr in March 2022 to ₹82.65 Cr in March 2023, and further projected to reach ₹127.92 Cr in March 2024. This growth trajectory illustrates a robust demand for its products, although there was a decline in reported sales to ₹78.09 Cr in March 2025. On a quarterly basis, the most recent figures indicate a quarterly sales high of ₹38.65 Cr in December 2023, reflecting a positive trend in the latter half of the fiscal year. However, the sales dipped to ₹11.70 Cr in June 2025, indicating potential seasonal fluctuations or challenges in maintaining consistent sales momentum. Overall, the sales figures suggest that while the company is expanding, it also faces volatility that could impact its revenue stability.
Profitability and Efficiency Metrics
Axel Polymers’ profitability metrics reveal a mixed performance. The operating profit margin (OPM) stood at 8.55%, indicating moderate efficiency in controlling costs relative to sales. However, this figure has seen considerable variability, with OPM peaking at 23.03% in March 2025 but also plummeting to 0.73% in June 2024. The net profit recorded a decline to ₹0.17 Cr in March 2025 from ₹1.18 Cr in March 2023, highlighting challenges in maintaining profitability. The return on equity (ROE) was low at 1.13%, while the return on capital employed (ROCE) was slightly better at 7.88%. The interest coverage ratio (ICR) of 1.27x suggests that the company has just enough earnings to cover its interest obligations, which is concerning given the high level of borrowings at ₹34.08 Cr. These profitability and efficiency metrics point towards areas needing improvement for sustainable growth.
Balance Sheet Strength and Financial Ratios
Axel Polymers’ balance sheet reflects significant leverage, with total borrowings amounting to ₹34.08 Cr against reserves of ₹6.62 Cr, resulting in a debt-to-equity ratio of 2.25x. This high leverage raises concerns about financial stability, especially in periods of lower profitability. The company’s current ratio stands at 1.19, indicating sufficient liquidity to meet short-term obligations, although the quick ratio of 0.32 suggests potential challenges in covering immediate liabilities without liquidating inventory. The book value per share has improved to ₹17.77 in March 2025, up from ₹14.47 in March 2022, suggesting some strengthening of underlying asset value despite the high debt levels. Moreover, the cash conversion cycle of 175.64 days indicates a prolonged period in converting inventory into cash, which could strain liquidity. These financial ratios highlight both strengths in liquidity management and weaknesses in leveraging and asset turnover.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Axel Polymers indicates strong promoter control, holding 61.16% of the equity as of March 2025, which may instill confidence among investors regarding management’s commitment. The presence of domestic institutional investors (DIIs) is minimal at 0.24%, reflecting limited institutional interest in the company. In contrast, public shareholding accounts for 38.60%, with a steady number of shareholders reported at 10,098. The stability in promoter holdings over recent quarters suggests a consistent strategy, but the lack of foreign institutional investment (FIIs) could indicate a perception of risk or undervaluation in international markets. The high public shareholding could also introduce volatility, as retail investors may react more sensitively to market fluctuations. Overall, while promoter confidence is high, the limited institutional presence may hinder broader market validation of the company’s growth prospects.
Outlook, Risks, and Final Insight
If margins sustain and the company effectively manages its costs, Axel Polymers could leverage its revenue growth to improve profitability significantly. However, risks remain, particularly due to high leverage and fluctuating sales patterns, which could pressure financial stability. Additionally, the prolonged cash conversion cycle may impact liquidity, making it essential for the company to optimize its operational efficiency. The ongoing reliance on promoter support might limit broader market appeal unless institutional interest increases. If the company can enhance operational efficiencies and stabilize its revenue streams, it may position itself for stronger financial health and investor confidence in the future. Addressing these challenges will be crucial for Axel Polymers as it navigates the competitive landscape of the plastics industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Axel Polymers Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mitsu Chem Plast Ltd | 136 Cr. | 100.0 | 138/83.2 | 18.2 | 71.4 | 0.20 % | 10.4 % | 8.17 % | 10.0 |
| IIRM Holdings India Ltd | 534 Cr. | 78.4 | 153/69.7 | 25.8 | 19.4 | 0.00 % | 23.5 % | 18.6 % | 5.00 |
| Fiberweb (India) Ltd | 128 Cr. | 44.7 | 66.0/34.0 | 7.49 | 61.2 | 0.00 % | 10.0 % | 8.88 % | 10.0 |
| Deep Polymers Ltd | 111 Cr. | 45.7 | 80.0/35.7 | 21.7 | 36.2 | 0.00 % | 8.22 % | 6.10 % | 10.0 |
| DDev Plastiks Industries Ltd | 3,169 Cr. | 306 | 360/213 | 16.2 | 80.7 | 0.57 % | 33.9 % | 24.9 % | 1.00 |
| Industry Average | 1,584.77 Cr | 498.36 | 47.71 | 157.76 | 0.27% | 16.30% | 12.17% | 8.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.82 | 21.45 | 17.74 | 27.18 | 25.81 | 30.92 | 38.65 | 37.28 | 42.24 | 13.87 | 11.11 | 14.33 | 11.70 |
| Expenses | 17.79 | 20.42 | 16.58 | 25.29 | 24.28 | 29.53 | 37.18 | 35.85 | 41.93 | 13.72 | 10.95 | 11.03 | 10.70 |
| Operating Profit | 1.03 | 1.03 | 1.16 | 1.89 | 1.53 | 1.39 | 1.47 | 1.43 | 0.31 | 0.15 | 0.16 | 3.30 | 1.00 |
| OPM % | 5.47% | 4.80% | 6.54% | 6.95% | 5.93% | 4.50% | 3.80% | 3.84% | 0.73% | 1.08% | 1.44% | 23.03% | 8.55% |
| Other Income | 0.05 | 0.08 | 0.03 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.09 | 0.01 |
| Interest | 0.72 | 0.76 | 0.82 | 0.86 | 0.80 | 0.78 | 0.67 | 0.62 | 0.75 | 0.85 | 0.81 | 0.82 | 0.82 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.24 | 0.12 | 0.12 | 0.12 | 0.34 | 0.12 | 0.12 | 0.12 | 0.20 | 0.15 |
| Profit before tax | 0.26 | 0.25 | 0.27 | 0.91 | 0.62 | 0.50 | 0.69 | 0.48 | -0.53 | -0.81 | -0.76 | 2.37 | 0.04 |
| Tax % | 0.00% | 0.00% | 0.00% | 54.95% | 0.00% | 0.00% | 2.90% | 114.58% | 0.00% | 0.00% | 0.00% | 5.91% | 0.00% |
| Net Profit | 0.26 | 0.25 | 0.27 | 0.41 | 0.62 | 0.50 | 0.67 | -0.07 | -0.53 | -0.81 | -0.76 | 2.23 | 0.04 |
| EPS in Rs | 0.31 | 0.29 | 0.32 | 0.48 | 0.73 | 0.59 | 0.79 | -0.08 | -0.62 | -0.95 | -0.89 | 2.62 | 0.05 |
Last Updated: August 1, 2025, 6:50 am
Below is a detailed analysis of the quarterly data for Axel Polymers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11.70 Cr.. The value appears to be declining and may need further review. It has decreased from 14.33 Cr. (Mar 2025) to 11.70 Cr., marking a decrease of 2.63 Cr..
- For Expenses, as of Jun 2025, the value is 10.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.03 Cr. (Mar 2025) to 10.70 Cr., marking a decrease of 0.33 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.30 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.30 Cr..
- For OPM %, as of Jun 2025, the value is 8.55%. The value appears to be declining and may need further review. It has decreased from 23.03% (Mar 2025) to 8.55%, marking a decrease of 14.48%.
- For Other Income, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.08 Cr..
- For Interest, as of Jun 2025, the value is 0.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.82 Cr..
- For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.20 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.05 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.37 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 2.33 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 5.91% (Mar 2025) to 0.00%, marking a decrease of 5.91%.
- For Net Profit, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.23 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 2.19 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.05. The value appears to be declining and may need further review. It has decreased from 2.62 (Mar 2025) to 0.05, marking a decrease of 2.57.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:50 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.56 | 16.19 | 18.53 | 21.94 | 26.97 | 24.37 | 22.90 | 48.32 | 72.91 | 82.65 | 127.92 | 78.09 | 51.01 |
| Expenses | 6.05 | 14.74 | 17.37 | 20.81 | 25.65 | 22.71 | 21.51 | 44.41 | 68.80 | 77.53 | 122.12 | 74.13 | 46.40 |
| Operating Profit | -0.49 | 1.45 | 1.16 | 1.13 | 1.32 | 1.66 | 1.39 | 3.91 | 4.11 | 5.12 | 5.80 | 3.96 | 4.61 |
| OPM % | -8.81% | 8.96% | 6.26% | 5.15% | 4.89% | 6.81% | 6.07% | 8.09% | 5.64% | 6.19% | 4.53% | 5.07% | 9.04% |
| Other Income | 0.03 | 0.04 | 0.08 | 0.27 | 0.04 | 0.02 | 0.02 | 0.40 | 0.55 | 0.28 | 0.04 | 0.14 | 0.12 |
| Interest | 0.87 | 0.88 | 0.84 | 0.93 | 0.79 | 0.91 | 0.97 | 3.32 | 2.84 | 3.16 | 2.85 | 3.23 | 3.30 |
| Depreciation | 0.45 | 0.48 | 0.25 | 0.21 | 0.28 | 0.33 | 0.36 | 0.42 | 0.48 | 0.54 | 0.70 | 0.56 | 0.59 |
| Profit before tax | -1.78 | 0.13 | 0.15 | 0.26 | 0.29 | 0.44 | 0.08 | 0.57 | 1.34 | 1.70 | 2.29 | 0.31 | 0.84 |
| Tax % | 0.00% | 0.00% | 0.00% | 15.38% | 17.24% | -6.82% | -12.50% | -15.79% | 31.34% | 30.59% | 31.88% | 41.94% | |
| Net Profit | -1.78 | 0.12 | 0.15 | 0.22 | 0.23 | 0.47 | 0.09 | 0.66 | 0.92 | 1.18 | 1.56 | 0.17 | 0.70 |
| EPS in Rs | -4.14 | 0.28 | 0.35 | 0.51 | 0.53 | 1.09 | 0.21 | 1.53 | 1.08 | 1.39 | 1.83 | 0.20 | 0.83 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 106.74% | 25.00% | 46.67% | 4.55% | 104.35% | -80.85% | 633.33% | 39.39% | 28.26% | 32.20% | -89.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -81.74% | 21.67% | -42.12% | 99.80% | -185.20% | 714.18% | -593.94% | -11.13% | 3.94% | -121.31% |
Axel Polymers Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 28% |
| 3 Years: | 2% |
| TTM: | -66% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | -43% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 40% |
| 3 Years: | 8% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 7% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:31 pm
Balance Sheet
Last Updated: October 10, 2025, 3:34 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 |
| Reserves | -3.31 | -3.44 | -3.29 | -3.09 | -2.84 | -2.37 | -2.31 | 2.90 | 3.81 | 5.01 | 6.47 | 6.62 |
| Borrowings | 5.00 | 4.38 | 5.46 | 5.69 | 7.46 | 7.55 | 7.46 | 25.90 | 25.94 | 25.19 | 25.67 | 34.08 |
| Other Liabilities | 3.98 | 10.22 | 6.66 | 6.96 | 6.30 | 5.06 | 6.86 | 14.25 | 17.09 | 16.50 | 23.56 | 18.20 |
| Total Liabilities | 9.97 | 15.46 | 13.13 | 13.86 | 15.22 | 14.54 | 16.31 | 51.57 | 55.36 | 55.22 | 64.22 | 67.42 |
| Fixed Assets | 3.72 | 3.03 | 2.81 | 3.50 | 3.60 | 3.86 | 3.66 | 7.83 | 7.71 | 8.84 | 9.77 | 10.18 |
| CWIP | 0.30 | 0.30 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 5.95 | 12.13 | 10.31 | 10.36 | 11.62 | 10.68 | 12.65 | 43.74 | 47.65 | 46.38 | 54.45 | 57.24 |
| Total Assets | 9.97 | 15.46 | 13.13 | 13.86 | 15.22 | 14.54 | 16.31 | 51.57 | 55.36 | 55.22 | 64.22 | 67.42 |
Below is a detailed analysis of the balance sheet data for Axel Polymers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 8.52 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.52 Cr..
- For Reserves, as of Mar 2025, the value is 6.62 Cr.. The value appears strong and on an upward trend. It has increased from 6.47 Cr. (Mar 2024) to 6.62 Cr., marking an increase of 0.15 Cr..
- For Borrowings, as of Mar 2025, the value is 34.08 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 25.67 Cr. (Mar 2024) to 34.08 Cr., marking an increase of 8.41 Cr..
- For Other Liabilities, as of Mar 2025, the value is 18.20 Cr.. The value appears to be improving (decreasing). It has decreased from 23.56 Cr. (Mar 2024) to 18.20 Cr., marking a decrease of 5.36 Cr..
- For Total Liabilities, as of Mar 2025, the value is 67.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.22 Cr. (Mar 2024) to 67.42 Cr., marking an increase of 3.20 Cr..
- For Fixed Assets, as of Mar 2025, the value is 10.18 Cr.. The value appears strong and on an upward trend. It has increased from 9.77 Cr. (Mar 2024) to 10.18 Cr., marking an increase of 0.41 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 57.24 Cr.. The value appears strong and on an upward trend. It has increased from 54.45 Cr. (Mar 2024) to 57.24 Cr., marking an increase of 2.79 Cr..
- For Total Assets, as of Mar 2025, the value is 67.42 Cr.. The value appears strong and on an upward trend. It has increased from 64.22 Cr. (Mar 2024) to 67.42 Cr., marking an increase of 3.20 Cr..
However, the Borrowings (34.08 Cr.) are higher than the Reserves (6.62 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.49 | -2.93 | -4.30 | -4.56 | -6.14 | -5.89 | -6.07 | -21.99 | -21.83 | -20.07 | -19.87 | -30.12 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 158.87 | 123.32 | 86.08 | 33.94 | 36.68 | 26.36 | 33.47 | 100.01 | 57.02 | 33.87 | 31.19 | 51.56 |
| Inventory Days | 130.41 | 127.01 | 102.73 | 123.25 | 113.12 | 146.24 | 184.09 | 218.96 | 166.83 | 168.33 | 125.70 | 215.52 |
| Days Payable | 180.68 | 175.90 | 38.81 | 36.63 | 19.49 | 20.20 | 62.21 | 125.81 | 95.43 | 80.23 | 71.47 | 91.43 |
| Cash Conversion Cycle | 108.60 | 74.43 | 150.00 | 120.56 | 130.30 | 152.40 | 155.35 | 193.16 | 128.43 | 121.97 | 85.42 | 175.64 |
| Working Capital Days | -115.54 | 4.51 | 47.27 | 12.48 | 20.71 | 13.33 | 18.33 | 33.16 | 27.78 | 30.74 | 24.77 | 29.87 |
| ROCE % | -12.36% | 17.99% | 16.91% | 17.35% | 13.65% | 14.67% | 11.09% | 16.63% | 11.06% | 12.63% | 12.95% | 7.88% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Diluted EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Cash EPS (Rs.) | 0.86 | 2.65 | 2.02 | 1.64 | 1.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Revenue From Operations / Share (Rs.) | 91.68 | 150.19 | 100.02 | 85.61 | 53.58 |
| PBDIT / Share (Rs.) | 4.82 | 6.84 | 6.34 | 5.48 | 3.74 |
| PBIT / Share (Rs.) | 4.16 | 6.02 | 5.70 | 4.91 | 2.88 |
| PBT / Share (Rs.) | 0.36 | 2.68 | 2.00 | 1.58 | 0.28 |
| Net Profit / Share (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.43 |
| PBDIT Margin (%) | 5.25 | 4.55 | 6.33 | 6.39 | 6.97 |
| PBIT Margin (%) | 4.53 | 4.00 | 5.70 | 5.73 | 5.37 |
| PBT Margin (%) | 0.39 | 1.78 | 1.99 | 1.84 | 0.53 |
| Net Profit Margin (%) | 0.22 | 1.21 | 1.39 | 1.25 | 0.81 |
| Return on Networth / Equity (%) | 1.14 | 10.37 | 8.75 | 7.43 | 8.58 |
| Return on Capital Employeed (%) | 16.17 | 22.87 | 23.95 | 23.85 | 16.73 |
| Return On Assets (%) | 0.25 | 2.41 | 2.12 | 1.65 | 0.85 |
| Long Term Debt / Equity (X) | 0.42 | 0.47 | 0.47 | 0.40 | 0.64 |
| Total Debt / Equity (X) | 2.25 | 1.71 | 1.86 | 2.10 | 3.99 |
| Asset Turnover Ratio (%) | 1.18 | 2.13 | 1.54 | 1.88 | 1.20 |
| Current Ratio (X) | 1.19 | 1.23 | 1.23 | 1.17 | 1.17 |
| Quick Ratio (X) | 0.32 | 0.28 | 0.30 | 0.42 | 0.40 |
| Inventory Turnover Ratio (X) | 2.09 | 3.33 | 2.37 | 3.08 | 1.82 |
| Interest Coverage Ratio (X) | 1.27 | 2.05 | 1.71 | 1.64 | 1.44 |
| Interest Coverage Ratio (Post Tax) (X) | 1.05 | 1.55 | 1.38 | 1.32 | 1.17 |
| Enterprise Value (Cr.) | 66.75 | 85.41 | 60.02 | 67.20 | 14.08 |
| EV / Net Operating Revenue (X) | 0.85 | 0.66 | 0.70 | 0.92 | 0.61 |
| EV / EBITDA (X) | 16.27 | 14.65 | 11.12 | 14.41 | 8.76 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| Price / BV (X) | 2.30 | 4.05 | 2.65 | 3.42 | 2.43 |
| Price / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| EarningsYield | 0.00 | 0.02 | 0.03 | 0.02 | 0.03 |
After reviewing the key financial ratios for Axel Polymers Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 2.65 (Mar 24) to 0.86, marking a decrease of 1.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 91.68. It has decreased from 150.19 (Mar 24) to 91.68, marking a decrease of 58.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.82. This value is within the healthy range. It has decreased from 6.84 (Mar 24) to 4.82, marking a decrease of 2.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.16. This value is within the healthy range. It has decreased from 6.02 (Mar 24) to 4.16, marking a decrease of 1.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 2.68 (Mar 24) to 0.36, marking a decrease of 2.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 2. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For PBDIT Margin (%), as of Mar 25, the value is 5.25. This value is below the healthy minimum of 10. It has increased from 4.55 (Mar 24) to 5.25, marking an increase of 0.70.
- For PBIT Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 10. It has increased from 4.00 (Mar 24) to 4.53, marking an increase of 0.53.
- For PBT Margin (%), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 10. It has decreased from 1.78 (Mar 24) to 0.39, marking a decrease of 1.39.
- For Net Profit Margin (%), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 5. It has decreased from 1.21 (Mar 24) to 0.22, marking a decrease of 0.99.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 15. It has decreased from 10.37 (Mar 24) to 1.14, marking a decrease of 9.23.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 22.87 (Mar 24) to 16.17, marking a decrease of 6.70.
- For Return On Assets (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to 0.25, marking a decrease of 2.16.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.42, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.25. This value exceeds the healthy maximum of 1. It has increased from 1.71 (Mar 24) to 2.25, marking an increase of 0.54.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.18. It has decreased from 2.13 (Mar 24) to 1.18, marking a decrease of 0.95.
- For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.19, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.32, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 4. It has decreased from 3.33 (Mar 24) to 2.09, marking a decrease of 1.24.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 3. It has decreased from 2.05 (Mar 24) to 1.27, marking a decrease of 0.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 24) to 1.05, marking a decrease of 0.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 66.75. It has decreased from 85.41 (Mar 24) to 66.75, marking a decrease of 18.66.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.85, marking an increase of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 16.27. This value exceeds the healthy maximum of 15. It has increased from 14.65 (Mar 24) to 16.27, marking an increase of 1.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 4.05 (Mar 24) to 2.30, marking a decrease of 1.75.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Axel Polymers Ltd:
- Net Profit Margin: 0.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.17% (Industry Average ROCE: 16.3%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.14% (Industry Average ROE: 12.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.32
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 60.8 (Industry average Stock P/E: 47.71)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Plastic & Plastic Products | 309, Mokshi, Vadodra District Gujarat 391780 | cs@axelindia.com http://www.axelpolymers.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Gaurav Thanky | Chairman & Managing Director |
| Mr. A B Bodhanwala | Executive Director & CFO |
| Mr. Haresh Kothari | Ind. Non-Executive Director |
| Mr. Umang Dasani | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Axel Polymers Ltd?
Axel Polymers Ltd's intrinsic value (as of 27 October 2025) is 9.98 which is 80.04% lower the current market price of 50.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 42.6 Cr. market cap, FY2025-2026 high/low of 64.0/27.7, reserves of ₹6.62 Cr, and liabilities of 67.42 Cr.
What is the Market Cap of Axel Polymers Ltd?
The Market Cap of Axel Polymers Ltd is 42.6 Cr..
What is the current Stock Price of Axel Polymers Ltd as on 27 October 2025?
The current stock price of Axel Polymers Ltd as on 27 October 2025 is 50.0.
What is the High / Low of Axel Polymers Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Axel Polymers Ltd stocks is 64.0/27.7.
What is the Stock P/E of Axel Polymers Ltd?
The Stock P/E of Axel Polymers Ltd is 60.8.
What is the Book Value of Axel Polymers Ltd?
The Book Value of Axel Polymers Ltd is 17.8.
What is the Dividend Yield of Axel Polymers Ltd?
The Dividend Yield of Axel Polymers Ltd is 0.00 %.
What is the ROCE of Axel Polymers Ltd?
The ROCE of Axel Polymers Ltd is 7.88 %.
What is the ROE of Axel Polymers Ltd?
The ROE of Axel Polymers Ltd is 1.13 %.
What is the Face Value of Axel Polymers Ltd?
The Face Value of Axel Polymers Ltd is 10.0.